$60.82 0.33 (+0.55%)
2/10/2012 4:02 PM

Medco Health Solutions, Inc. (NYSE:MHS)

CAPS Rating: 5 out of 5

Provides sophisticated traditional and specialty prescription drug benefit programs and services for clients, members of client-funded benefit plans and individual patients.

Results 1 - 20 of 149 : 1 2 3 4 5 6 7 8 Next »

Recs

0
Member Avatar pchop123 (70.20) Submitted: 2/10/2012 3:35:39 PM : Outperform Start Price: $60.71 MHS Score: -0.01

solid player with low PE

Recs

0
Member Avatar cotom8405 (31.70) Submitted: 2/6/2012 8:14:03 PM : Outperform Start Price: $59.57 MHS Score: +1.96

good value whether the xprs acq goes thru or not at this price.

$64 (alone) or $71 (with acq).

Recs

0
Member Avatar EBStroke (< 20) Submitted: 2/6/2012 8:04:06 PM : Underperform Start Price: $59.57 MHS Score: -1.96

negative news on potential merger

Recs

0
Member Avatar gregdino (< 20) Submitted: 2/6/2012 3:45:35 PM : Outperform Start Price: $58.26 MHS Score: +4.44

buyout target, which will fail

Recs

0
Member Avatar progressisslow (< 20) Submitted: 2/2/2012 2:37:59 PM : Underperform Start Price: $62.93 MHS Score: +4.69

I Bought this stock in Jan 'io . It has gone down and up to where I bought it and down and up. I bought at the top and it still hasn't made any money. It looks like it goes down every year about august or oct. I am readuy to sell if it comes close to what I paid for it ($64.84). I could keep it on my watch list and buy it when it goes down.

Recs

0
Member Avatar MHenage (< 20) Submitted: 2/1/2012 1:58:42 PM : Outperform Start Price: $62.92 MHS Score: -4.48

Positive free cash flow of nearly $447 million average per quarter in the last year - good enough for me.

Recs

0
Member Avatar dreamjob (75.51) Submitted: 12/20/2011 5:25:35 PM : Outperform Start Price: $55.47 MHS Score: +1.23

FCF is outpacing NI, CROIC / ROIC in the double digits (16 & 18% respectively by my calculations), DSO is stable with solid revenue and earnings growth. Priced right at $55.56.

Recs

0
Member Avatar Guin3666 (71.78) Submitted: 9/20/2011 9:59:39 AM : Outperform Start Price: $50.50 MHS Score: +9.08

ppt + research + merger

Recs

0
Member Avatar farmboy1960 (36.26) Submitted: 8/12/2011 9:17:14 PM : Outperform Start Price: $54.00 MHS Score: -0.10

Medco supplies mail order drugs for companies health plans. They are well positioned to take advantage on a National Health Plan but will do well if it is not implemented also. Ever increasing numbers of senior citizens are going to need ever increasing prescription drugs.

Recs

0
Member Avatar secretbonus (33.43) Submitted: 8/10/2011 11:30:06 AM : Outperform Start Price: $49.35 MHS Score: +9.89

simply using it and the M+A to aquire ESRX at a discount.

Recs

0
Member Avatar goldilocks52 (< 20) Submitted: 6/23/2011 7:05:53 PM : Outperform Start Price: $54.24 MHS Score: +7.27

Bound to rise once healthcare plan takes off.

Recs

0
Member Avatar GrumpyGopher (43.00) Submitted: 4/27/2011 2:26:43 PM : Outperform Start Price: $58.55 MHS Score: +4.34

My employer uses this service for perscriptions, and I imagine other large companies do as well. People are getting older and we are a pill popping culture.

Recs

0
Member Avatar TMFRisingStars (48.42) Submitted: 4/20/2011 2:19:23 PM : Outperform Start Price: $58.51 MHS Score: +2.85

Here's the buy rec:

http://www.fool.com/investing/general/2011/04/19/rising-star-buy-medco-health.aspx

Recs

2
Member Avatar inkstainedwretch (52.07) Submitted: 3/23/2011 5:12:11 AM : Outperform Start Price: $53.26 MHS Score: +9.98

two sets of two words: "Baby Boomers" and "Old now"

If MHS sold diapers, big cars and Fresca, it would be my largest and only holding.

Recs

0
Member Avatar gtforr (< 20) Submitted: 3/22/2011 5:55:40 AM : Outperform Start Price: $52.61 MHS Score: +12.03

near trough PE ratio of ~11 on '12 estimates.
Predictable earnings stream. History of growth in a flat market over past decade+.

Recs

0
Member Avatar 94impala (< 20) Submitted: 2/24/2011 4:57:41 PM : Outperform Start Price: $61.89 MHS Score: -3.92

This company fully benefits from the generic drug fiasco. Not going anywhere, even in bad times.

Recs

0
Member Avatar metalmilitia (< 20) Submitted: 2/19/2011 6:42:18 PM : Outperform Start Price: $62.77 MHS Score: -4.16

It's growing and has generics. The healthcare bill should help boost it.

Recs

0
Member Avatar tharbold (33.27) Submitted: 2/5/2011 1:37:08 PM : Outperform Start Price: $62.63 MHS Score: -5.11

aging population, key drugs going generic over the next year ... will drive margins and profit for MHS

Recs

0
Member Avatar Highlander1891 (< 20) Submitted: 2/4/2011 4:09:35 PM : Outperform Start Price: $62.63 MHS Score: -5.11

This company has been around for a long time with a successful track record in health care. The company has some new products to hit the market in next 12 months that will be in high demand by consumers.

Recs

0
Member Avatar gweech (85.87) Submitted: 2/4/2011 8:46:41 AM : Outperform Start Price: $62.17 MHS Score: -4.87

A ton of baby boomers in need of generics and a ton of patents up in the next few years. Medco is a well run company.

Featured Broker Partners


Advertisement